Metformin inhibits the proliferation of human prostate cancer PC-3 cells via the downregulation of insulin-like growth factor 1 receptor
- 1 May 2015
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 461 (1) , 115-121
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Metformin Use and All-Cause and Prostate Cancer–Specific Mortality Among Men With DiabetesJournal of Clinical Oncology, 2013
- Metformin in prostate cancer: two for the price of oneAnnals of Oncology, 2011
- Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptorBiochemical and Biophysical Research Communications, 2008
- The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 levelOncogene, 2008
- The insulin-like growth factor 1 receptor in cancer: Old focus, new futureEuropean Journal of Cancer, 2007
- Metformin and reduced risk of cancer in diabetic patientsBMJ, 2005
- In vivo Effects of the Human Type I Insulin-Like Growth Factor Receptor Antibody A12 on Androgen-Dependent and Androgen-Independent Xenograft Human Prostate TumorsClinical Cancer Research, 2005
- Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC‐3International Journal of Cancer, 2002
- Inhibition of integrin-linked kinase (ILK) suppresses activation of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTEN-mutant prostate cancer cellsProceedings of the National Academy of Sciences, 2000
- Insulin-like Growth Factors and Prostate CancerCancer and Metastasis Reviews, 1998